Please enable JavaScript to continue using this application.

Compare $FHTX vs $TNXP | Chartloom

Compare

$FHTX vs $TNXP

Foghorn Therapeutics Inc · Tonix Pharmaceuticals Holding Corp

FHTX

Foghorn Therapeutics Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Compare $FHTX vs $TNXP

Comparing Foghorn Therapeutics Inc and Tonix Pharmaceuticals Holding Corp

FHTXFoghorn Therapeutics Inc

TNXPTonix Pharmaceuticals Holding Corp

FHTXFoghorn Therapeutics Inc

Market cap

$117M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.04x

Rev growth (TTM)

52.0%

YTD performance

-61.5%

52W performance

-55.6%

FCF yield

-71.8%

TNXPTonix Pharmaceuticals Holding Corp

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.39x

Rev growth (TTM)

196.0%

YTD performance

-55.9%

52W performance

-67.5%

FCF yield

-135.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FHTX

TNXP

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

FHTX$117M

TNXP$116M

Enterprise Value

FHTX$49M

TNXP$-60M

Price

FHTX$2.00

TNXP$7.30

P/E Ratio

FHTXN/A

TNXPN/A

P/S Ratio

FHTX3.20x

TNXP4.00x

EV/Sales

FHTX1.34x

TNXP-2.06x

EV/EBITDA

FHTX0.00x

TNXP0.00x

P/B Ratio

FHTX1,199.58x

TNXP0.69x

P/FCF Ratio

FHTXN/A

TNXPN/A

EV/FCF

FHTX-0.59x

TNXP0.38x

PEG Ratio

FHTXN/A

TNXPN/A

Forward P/E (NTM)

FHTXN/A

TNXPN/A

Forward P/S (NTM)

FHTX4.04x

TNXP1.39x

Revenue (TTM)

FHTX$37M

TNXP$29M

Revenue Growth (YoY)

FHTX52.0%

TNXP196.0%

Forward Rev Growth

FHTX7.3%

TNXP101.6%

Gross Margin (TTM)

FHTX0.0%

TNXP83.8%

Operating Margin (TTM)

FHTX0.0%

TNXP0.0%

EBITDA Margin (TTM)

FHTX-180.6%

TNXP-561.1%

Net Margin (TTM)

FHTX-175.8%

TNXP-548.6%

FCF Margin (TTM)

FHTX-229.4%

TNXP-543.3%

Net Income (TTM)

FHTX$-65M

TNXP$-160M

FCF (TTM)

FHTX$-84M

TNXP$-158M

EPS (TTM)

FHTX-$0.91

TNXP-$9.60

ROE (TTM)

FHTX-30161.0%

TNXP-6899.0%

ROA (TTM)

FHTX-3117.0%

TNXP-6132.0%

ROIC (TTM)

FHTX-30161.0%

TNXP-6899.0%

Cash

FHTX$68M

TNXP$176M

Debt

FHTX$0

TNXP$0

Net Cash/Debt

FHTX$68M

TNXP$176M

Current Ratio (TTM)

FHTX3.36x

TNXP6.61x

Quick Ratio (TTM)

FHTX3.31x

TNXP6.13x

Debt/Equity (TTM)

FHTX0.00x

TNXP0.00x

Debt/Assets (TTM)

FHTX0.0%

TNXP0.0%

Interest Coverage (TTM)

FHTXN/A

TNXPN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

TNXP0.00x

Beta

FHTX3.13

TNXP1.87

52W Performance

FHTX-55.6%

TNXP-67.5%

YTD Performance

FHTX-61.5%

TNXP-55.9%

% from 52W High

FHTX-73.7%

TNXP-68.3%

% from 52W Low

FHTX11.7%

TNXP3.0%

Asset Turnover (TTM)

FHTX0.18x

TNXP0.11x

FCF Yield (TTM)

FHTX-71.8%

TNXP-135.9%

Earnings Yield (TTM)

FHTX-55.0%

TNXP-137.2%

Dividend Yield (TTM)

FHTXN/A

TNXPN/A

Rule of 40

FHTX-177.4

TNXP-347.3

EV/GP/RG

FHTXN/A

TNXPN/A

Ticker research

View FHTX research View TNXP research

Metric	FHTX Foghorn Therapeutics Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$117M	$116M
Enterprise Value	$49M	$-60M
Price	$2.00	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	4.00x
EV/Sales	1.34x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	1.39x
Revenue & Growth
Revenue (TTM)	$37M	$29M
Revenue Growth (YoY)	52.0%	196.0%
Forward Rev Growth	7.3%	101.6%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	-561.1%
Net Margin (TTM)	-175.8%	-548.6%
FCF Margin (TTM)	-229.4%	-543.3%
Net Income (TTM)	$-65M	$-160M
FCF (TTM)	$-84M	$-158M
EPS (TTM)	-$0.91	-$9.60
ROE (TTM)	-30161.0%	-6899.0%
ROA (TTM)	-3117.0%	-6132.0%
ROIC (TTM)	-30161.0%	-6899.0%
Financial Health
Cash	$68M	$176M
Debt	$0	$0
Net Cash/Debt	$68M	$176M
Current Ratio (TTM)	3.36x	6.61x
Quick Ratio (TTM)	3.31x	6.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	1.87
52W Performance	-55.6%	-67.5%
YTD Performance	-61.5%	-55.9%
% from 52W High	-73.7%	-68.3%
% from 52W Low	11.7%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.11x
FCF Yield (TTM)	-71.8%	-135.9%
Earnings Yield (TTM)	-55.0%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View TNXP research

Valuation

P/S Ratio

FHTX

3.20x

TNXP

4.00x

EV/FCF

FHTX

-0.59x

TNXP

0.38x

Growth & revenue

Revenue Growth TTM

TNXP

196.0%

FHTX

52.0%

Forward Revenue Growth

TNXP

101.6%

FHTX

7.3%

Profitability & performance

Gross Margin

TNXP

83.8%

FHTX

0.0%

ROE

TNXP

-6899.0%

FHTX

-30161.0%

FCF Yield %

FHTX

-71.8%

TNXP

-135.9%

52-Week Performance

FHTX

-55.6%

TNXP

-67.5%

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

FHTX$117M

TNXP$116M

Enterprise Value

FHTX$49M

TNXP$-60M

Price

FHTX$2.00

TNXP$7.30

P/E Ratio

FHTXN/A

TNXPN/A

P/S Ratio

FHTX3.20x

TNXP4.00x

EV/Sales

FHTX1.34x

TNXP-2.06x

EV/EBITDA

FHTX0.00x

TNXP0.00x

P/B Ratio

FHTX1,199.58x

TNXP0.69x

P/FCF Ratio

FHTXN/A

TNXPN/A

EV/FCF

FHTX-0.59x

TNXP0.38x

PEG Ratio

FHTXN/A

TNXPN/A

Forward P/E (NTM)

FHTXN/A

TNXPN/A

Forward P/S (NTM)

FHTX4.04x

TNXP1.39x

Revenue (TTM)

FHTX$37M

TNXP$29M

Revenue Growth (YoY)

FHTX52.0%

TNXP196.0%

Forward Rev Growth

FHTX7.3%

TNXP101.6%

Gross Margin (TTM)

FHTX0.0%

TNXP83.8%

Operating Margin (TTM)

FHTX0.0%

TNXP0.0%

EBITDA Margin (TTM)

FHTX-180.6%

TNXP-561.1%

Net Margin (TTM)

FHTX-175.8%

TNXP-548.6%

FCF Margin (TTM)

FHTX-229.4%

TNXP-543.3%

Net Income (TTM)

FHTX$-65M

TNXP$-160M

FCF (TTM)

FHTX$-84M

TNXP$-158M

EPS (TTM)

FHTX-$0.91

TNXP-$9.60

ROE (TTM)

FHTX-30161.0%

TNXP-6899.0%

ROA (TTM)

FHTX-3117.0%

TNXP-6132.0%

ROIC (TTM)

FHTX-30161.0%

TNXP-6899.0%

Cash

FHTX$68M

TNXP$176M

Debt

FHTX$0

TNXP$0

Net Cash/Debt

FHTX$68M

TNXP$176M

Current Ratio (TTM)

FHTX3.36x

TNXP6.61x

Quick Ratio (TTM)

FHTX3.31x

TNXP6.13x

Debt/Equity (TTM)

FHTX0.00x

TNXP0.00x

Debt/Assets (TTM)

FHTX0.0%

TNXP0.0%

Interest Coverage (TTM)

FHTXN/A

TNXPN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

TNXP0.00x

Beta

FHTX3.13

TNXP1.87

52W Performance

FHTX-55.6%

TNXP-67.5%

YTD Performance

FHTX-61.5%

TNXP-55.9%

% from 52W High

FHTX-73.7%

TNXP-68.3%

% from 52W Low

FHTX11.7%

TNXP3.0%

Asset Turnover (TTM)

FHTX0.18x

TNXP0.11x

FCF Yield (TTM)

FHTX-71.8%

TNXP-135.9%

Earnings Yield (TTM)

FHTX-55.0%

TNXP-137.2%

Dividend Yield (TTM)

FHTXN/A

TNXPN/A

Rule of 40

FHTX-177.4

TNXP-347.3

EV/GP/RG

FHTXN/A

TNXPN/A

Ticker research

View FHTX research View TNXP research

Metric	FHTX Foghorn Therapeutics Inc	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$117M	$116M
Enterprise Value	$49M	$-60M
Price	$2.00	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	4.00x
EV/Sales	1.34x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	1.39x
Revenue & Growth
Revenue (TTM)	$37M	$29M
Revenue Growth (YoY)	52.0%	196.0%
Forward Rev Growth	7.3%	101.6%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	-561.1%
Net Margin (TTM)	-175.8%	-548.6%
FCF Margin (TTM)	-229.4%	-543.3%
Net Income (TTM)	$-65M	$-160M
FCF (TTM)	$-84M	$-158M
EPS (TTM)	-$0.91	-$9.60
ROE (TTM)	-30161.0%	-6899.0%
ROA (TTM)	-3117.0%	-6132.0%
ROIC (TTM)	-30161.0%	-6899.0%
Financial Health
Cash	$68M	$176M
Debt	$0	$0
Net Cash/Debt	$68M	$176M
Current Ratio (TTM)	3.36x	6.61x
Quick Ratio (TTM)	3.31x	6.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	1.87
52W Performance	-55.6%	-67.5%
YTD Performance	-61.5%	-55.9%
% from 52W High	-73.7%	-68.3%
% from 52W Low	11.7%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.11x
FCF Yield (TTM)	-71.8%	-135.9%
Earnings Yield (TTM)	-55.0%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View TNXP research